{"id":"W4392551856","doi":"10.1111/jdv.19925","title":"Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (<scp>POETYK PSO</scp>‐1 and <scp>PSO</scp>‐2)","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Placebo; Tolerability; Adverse effect; Discontinuation; Internal medicine; Apremilast; Psoriasis; Incidence (geometry); Population; Gastroenterology; Dermatology; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00231089,0.0004884923,0.001794242,0.0004111278,0.0002510719,0.00003786211,0.0004790447,0.0006596514,0.0000357337],"category_scores_gemma":[0.001271877,0.0003473604,0.0002859276,0.0002555189,0.0007160577,0.0002375466,0.0003758891,0.001203864,0.00002760379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004290111,"about_ca_system_score_gemma":0.0001111668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003269702,"about_ca_topic_score_gemma":0.00002438839,"domain_scores_codex":[0.9912112,0.005697358,0.001816092,0.0006095057,0.00009268137,0.0005731725],"domain_scores_gemma":[0.9944078,0.004308775,0.0008299592,0.0002441436,0.00006293559,0.0001463442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0111368,0.001970067,0.4920551,0.0008681043,0.01420044,0.002473853,0.01925106,0.0004043759,0.2508476,0.0140179,0.03652908,0.1562456],"study_design_scores_gemma":[0.07591724,0.001049718,0.5371831,0.001524405,0.005755548,0.03540231,0.002074861,0.0004341508,0.130376,0.02837887,0.1810934,0.000810319],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9567143,0.03817935,0.0001368102,0.002642207,0.001063772,0.0003711595,0.0002141401,0.00003192978,0.000646315],"genre_scores_gemma":[0.9941762,0.004195514,0.0002112954,0.0007242218,0.0002534049,0.000006328398,0.0000212203,0.00004368605,0.000368094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1554353,"threshold_uncertainty_score":0.9998978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02740083357130022,"score_gpt":0.2952976864391373,"score_spread":0.2678968528678371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}